Get the Stockscreener App
74.98
0.05%
-0.04
Hologic Inc stock is traded at $74.98, with a volume of 4.14M.
It is down -0.05% in the last 24 hours and down -0.05% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$75.02
Open:
$75
24h Volume:
4.14M
Relative Volume:
1.21
Market Cap:
$16.73B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
31.11
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
+0.15%
1M Performance:
-0.05%
6M Performance:
+17.41%
1Y Performance:
+7.16%
1-Day Range:
$74.91
$75.16
1-Week Range:
$74.81
$75.17
52-Week Range:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.98 | 16.73B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Argus | Buy → Hold |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-21-25 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
How low can spreads go? Hologic’s mega LBO tests the limit - PitchBook
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hologic wraps massive syndicated LBO loan - PitchBook
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - Nasdaq
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途牛牛
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Barchart.com
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
1 Healthcare Stock Worth Investigating and 2 That Underwhelm - Finviz
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer ScreeningHologic, Inc. - Hologic, Inc. - Investor Relations
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic (NASDAQ:HOLX) Downgraded by Argus to "Hold" - MarketBeat
Blackstone (BX) Involved in Hologic Acquisition Deal - GuruFocus
SG Americas Securities LLC Grows Position in Hologic, Inc. $HOLX - MarketBeat
Is Hologic Inc. stock affected by interest rate hikesPortfolio Update Summary & Daily Risk Controlled Trade Plans - Улправда
(HOLX) Risk Channels and Responsive Allocation - Stock Traders Daily
What market sentiment indicators show for Hologic Inc. (HO1) stock2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Why Hologic Inc. stock is recommended by analystsJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
Hologic issues safety alert for breast biopsy needles - Radiology Business
Why Hologic Inc. stock appeals to analystsInflation Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Will Hologic Inc. (HO1) stock test record highs in 20252025 Price Targets & Verified Swing Trading Watchlists - ulpravda.ru
Why Hologic Inc. stock is seen as undervaluedJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - ulpravda.ru
Will Hologic Inc. stock outperform Dow Jones indexGlobal Markets & High Accuracy Trade Signal Alerts - ulpravda.ru
Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Can Hologic Inc. stock deliver surprise earnings beatMarket Trend Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Will Hologic Inc. stock deliver consistent dividends2025 Macro Impact & Growth Focused Entry Point Reports - ulpravda.ru
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of Hologic's Earnings Release - Barchart.com
Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc.HOLX - PR Newswire
Blackstone, TPG Deliver a $7 Billion Test to Risky Loan Market - Bloomberg.com
Assessing Hologic (HOLX) Valuation After Recent Three Month Share Price Momentum - Yahoo Finance
Is Hologic (HOLX) Pricing Look Interesting After Recent Flat Share Performance - Sahm
Is Hologic Inc. stock cheap compared to fundamentals2026 world cup usa national team round of 32 defensive leaders build up play tactical prediction statistical analysis - ulpravda.ru
Hologic downgraded to ’B+’ by S&P after take-private deal - Investing.com Nigeria
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? - The Globe and Mail
How sustainable is Hologic Inc. stock dividend payout2026 world cup usa national team semifinals young talents build up play group prediction expert opinion - ulpravda.ru
Wall Street Banks Kick Off $7 Billion Loan Sale Tied to Hologic Buyout - Bloomberg.com
Hologic Mammography Market Size to Hit USD 8.82 Billion by 2035 - Precedence Research
Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | - openPR.com
Hologic Trading Near 52-Week High: How Should You Play the Stock? - Finviz
Hologic Inc. stock underperforms Thursday when compared to competitors - MSN
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
7.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):